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*Escherichia coli* is a Gram-negative microorganism belonging to the *Enterobacteriaceae* family, which is usually found, as commensal, in the enteric tract of many animal species. However, several *E. coli* strains can cause a wide range of clinical symptoms in humans and animals, due to the expression of particular virulence factors, whereby *Escherichia coli* strains have been classified in different pathogroups (Gyles, [@ref33]).

The pathogroup of Shiga toxin-producing *Escherichia coli* (STEC or VTEC) is characterised by the production of one or both cytotoxins, known as Verotoxins or Shiga toxins (Stx1 and Stx2). Stx1 and Stx2 are immunologically distinct. In fact, they have approximately 56% of the amino acid sequence in common. Shiga toxins are encoded by genes -- *stx1* and *stx2* -- generally carried by prophages; *stx* gene expression occurs when the lytic cycle of the phage is induced (Bergan *et al*., [@ref2]).

Several variants of both Shiga toxins have been identified. According to the nomenclature system Scheutz *et al*. ([@ref3]) proposed, Stx1 subtypes found in *E. coli* are designed as Stx1a, Stx1c, and Stx1d, whereas Stx2 consists of seven variants, indicated from Stx2a to Stx2g. STEC strains can express a combination of one or more *stx* subtypes (Karve and Weiss, [@ref43]). However, epidemiological studies have shown that Stx2 is more associated with severe human disease than is Stx1, and strains producing Stx2a and Stx2c seem to be more commonly isolated in patients with HUS than are those producing other Stx variants (Caprioli *et al*., [@ref14]). Moreover, some Stx2 variants are often produced by strains of animal origin and are occasionally found in human isolates: stx~2e~ is mainly observed in pigs and stx~2f~ is described, especially in strains of avian origin (Caprioli *et al*., [@ref14]). However, to understand the role of these strains as human pathogens, further studies are needed (Friesema *et al*., [@ref29]).

Unlike cattle that do not typically have any STEC-associated symptoms (Tseng *et al*., [@ref69]), swine may present clinical disease due to STEC infection (Tseng *et al*., [@ref70]). Oedema disease, an infectious illness that often affects post-weaning piglets and young finishing-age pigs, is caused by *E. coli* strains harbouring the *stx~2e~* gene, encoding stx~2e~. In several countries, cross-sectional epidemiological studies have been conducted on the prevalence of STEC in clinically healthy swine. STEC prevalence ranges from 0% to 68.3% (Tseng *et al*., [@ref70]). Studies about prevalence of STEC O157:H7 in the United States estimate low values, ranging from 0% to 1.9%. In a more recent survey, STEC strains were isolated from 65.3% of faecal samples collected from pigs during the finishing period. Most of the STEC isolates carried the *stx~2e~* gene (97.9%) and belonged to serotype O59:H21 (73.6%) (Tseng *et al*., [@ref70]). A study conducted in China reported a high prevalence of STEC (25.42%) in healthy pigs found using PCR screening, although only 6.18% of the swine specimens gave a positive result by microbiological culture. All STEC isolates harboured *stx~2e~* and none of the strains belonged to the *top five* serogroups (O:157, O:145, O:103, O:111, O:26) (Meng *et al.*, [@ref51]).

Many STEC that are highly pathogenic to human beings, included in the Enterohaemorrhagic *E. coli* group (EHEC), are often characterised by the production of an outer membrane protein called intimin. This protein mediates the attachment of bacteria to enterocytes and induces cytoskeletal changes, with accumulation of actin, causing characteristic histopathologic lesions, defined as *attaching and effacing* (A/E). Intimin encoding gene *(eae)*, which belongs to a large pathogenicity island (PAI) called locus of enterocyte effacement (LEE), is an important additional virulence factor. Based on the amino acid sequence and antigenic differences, several intimin types have been identified: intimin α is generally found in Enteropathogenic *E. coli* (EPEC), intimin type **γ** is often associated with highly pathogenic STEC serogroups such as O:157, O:111 and O:145, and intimin ε is produced by STEC O:121 and O:103. Intimin β can be found in EPEC and STEC, in particular in EHEC O:26 (Caprioli *et al.*, [@ref14]).

The presence *of eae* gene is strongly associated with some STEC serotypes (O157:H7, O157:NM, O26:H11, O111:NM, O103:H2, O121:H19, and O145:NM) involved in outbreaks of HC and HUS. However, *eae*-negative strains, such as O91:H21, O113:H21 and more recently O104:H4, have been associated with serious disease, underlining the importance of other virulence factors (Bouvet *et al.*, [@ref11], [@ref12]). Other factors located on mobile genetic elements, like PAI or plasmids, have been identified. Nevertheless, in some cases, their role in the pathogenic process has not been fully elucidated (Caprioli *et al.*, [@ref14]). A wide range of plasmidic putative virulence factors is described in STEC strains. The gene *saa*, which codifies for autoagglutinating adhesin Saa, has been found on the large plasmid in LEE-negative STEC strains (*e.g.*, O113:H21, O91:H2) (EFSA, [@ref19]; Gyles, [@ref33]). Synthesis and transport of enterohaemolysin are encoded by the *hly* operon, located on the large plasmid pO157, characteristic of STEC O157 and some other STEC serogroups (Caprioli *et al*., [@ref14]). The plasmid-encoded haemolysin can be produced by both *eae*-positive and *eae*-negative STEC (Gyles, [@ref33]). Other putative virulence factors harboured by plasmid pO157 are comprised of catalase-peroxydase, encoded by the *katP* gene, and a serine protease, encoded by the *espP* gene (Caprioli *et al*., [@ref14]). Furthermore, different *E. coli* strains may belong to more than one pathotype group. For example, *E. coli* O104:H4, involved in Germany's outbreak in 2011, was positive for Verocytotoxin 2 gene (*stx2*) and also harboured *aaiC* and *aggR* virulence genes, which are typical of Enteroaggeregative *E. coli* (EAEC) (Frank *et al*., [@ref27]).

STEC infections are reported in a wide range of both domestic and wild animal species (*e.g.*, calves' dysentery, pigs' oedema disease, cutaneous and renal vasculopathy in Greyhound dogs), but human infections are relatively uncommon (Caprioli *et al*., [@ref14]). In a report of the European Food Safety Authority (EFSA), the prevalence of STEC in overall EU is about 1.2 cases per 100,000 of the population (EFSA, [@ref19]). STEC infection may result in severe illnesses, such as haemorrhagic colitis (HC) and haemolytic uraemic syndrome (HUS). Children less than five year years of age and the elderly are especially susceptible to severe complications (Gyles, [@ref33]). The term Enterohaemorrhagic *E. coli* (EHEC) indicates the subset of STEC strains that has been firmly associated with these severe symptoms. In many countries, O157:H7 is the serotype associated with most cases of disease, but outbreaks caused by non-O157 EHEC strains, like O26, O111, O103 and O145, have been increasingly described (Caprioli *et al*., [@ref14]).

In 2003, Karmali *et al*. proposed a STEC classification model, based on seropathotypes. This approach classifies STEC according to function of serotypes, frequency of involvement in outbreaks and disease incidence and severity. However, the O104:H4 outbreak in 2011 demonstrated the difficulty of predicting the emergence of non-O157 pathogenic STEC strains by focusing on a restricted panel of serogroups. Because of the impossibility of clearly defining STEC seropathotypes, the EFSA BIOHAZ Panel made a series of recommendations relating to the public health investigation of STEC infections. A molecular approach, utilising genes encoding virulence characteristics in addition to the presence of *stx* genes in isolates from human, food and animal sources, is proposed (Eriksson *et al*., [@ref21]).

STEC are zoonotic agents that can be transmitted to humans through person-to-person contact, ingestion of food or water contaminated with animal faeces, and by direct contact with animals (Caprioli *et al*., [@ref14]; Smith *et al*., [@ref65]). Although STEC have frequently been isolated from the intestinal content of a wide range of animal species, ruminants, especially cattle, are recognised as their main natural STEC reservoir. Cattle are usually asymptomatic excretors of the microorganism, which is a transient commensal member of the intestinal micro flora (Caprioli *et al*., [@ref14]; Bolton, [@ref6]). On the contrary, few epidemiologic data are available about monogastric animals and do not clearly elucidate the role of these species as a source of human pathogenic STEC (EFSA, [@ref19]).

Swine role in Shiga toxin-producing *Escherichia coli* epidemiology {#sec1-2}
===================================================================

In the scientific report of the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC) on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks (EFSA and ECDC, [@ref20]) in 2013, campylobacteriosis is the most commonly reported zoonosis, showing a stabilised trend of human case notification during the period of 2009--2013. The decreasing EU trend in confirmed human salmonellosis cases observed in recent years has continued, while human listeriosis has increased. Also, the number of confirmed verocytotoxigenic *Escherichia coli* infections in humans increased. In 2013, 6043 confirmed cases of STEC infections were reported in the EU, with a notification rate of 1.59 cases per 100,000 population, which was 5.9% higher than in 2012. The most commonly reported serogroups in 2013 were O:157, followed by O:26. In Italy, 65 confirmed cases of human infections were reported in 2013, and 50 human cases were confirmed in 2012. STEC was also reported in the EU from food and animals. These data on STEC detection are collected annually on a mandatory basis by EU Member States (MS) to European Commission and EFSA, based on Directive 2003/99/EC (European Commission, [@ref22]). Data on STEC detected in food confirm the important role of cattle as a source of food-borne STEC infections. In 2013, a total of 3898 fresh bovine meat samples and 860 raw milk specimens were tested, and 2.5% and 2.3%, respectively, were STEC-positive. In addition, six MS (including

Italy) reported testing of 447 fresh pig meat samples from processing plants, retail venues and slaughterhouses, with no positive STEC findings. Regarding the detection of STEC from animal samples, just three MS (Italy, Germany and Netherlands) collected data on STEC in pigs and only Germany (17.0% positive animals) and Netherlands (15.8% positive pens) found STEC-positive results. The overall proportion of STEC-positive units was 16.7%. This positivity rate is higher than data reported in cattle. The overall proportion of positive STEC units found by seven MS in cattle was 6.7%. It is important to note that the MS to STEC detection from food and animals used different sampling strategies and analytical methods. Consequently, data from different investigations are not necessarily directly comparable (EFSA and ECDC, [@ref20]).

Although cattle is suggested as the most important animal reservoir of STEC, very little is known about the occurrence of STEC in other domestic animals (Beutin *et al*., [@ref3]). The prevalence of STEC in the swine population, the presence of STEC in pork products and the incidence of pork-associated STEC outbreaks have been reported in some epidemiologic studies in multiple countries. However, these data are sparse and not directly comparable. The discrepancies are attributable to several factors, such as the different study designs, the application of various sample collection methods or STEC detection and isolation protocols (Tseng *et al*., [@ref70]).

The occurrence of STEC in swine faecal samples varies with a wide range of values, depending on the study. In Europe, STEC detection in the swine population has been described in several countries. A study conducted in Belgium reported a high prevalence of STEC from individual rectal swabs (56/177, 31%). In multiplex PCR, the serotype O157, assayed using PCR of the *rfbE* gene, was present in 30% (43/143) of tested swabs (Botteldoorn *et al*., [@ref10]). Similarly, in France, about 31% (129/182) of faecal samples tested using PCR were *stx-*positive, but among the 129 positive specimens, none contained a detectable *uidA* gene from O157:H7 (Bouvet *et al*., [@ref13]). In Switzerland, of 630 faecal samples collected at slaughter, 22% and 7.5% were positive using a PCR for *stx* and *rfbE*, respectively (Kaufmann *et al*., [@ref44]). In a study conducted in northern Italy in 1993, faecal specimens from 242 slaughtered pigs were tested using the Vero cell assay, and the presence of STEC was assessed in 7.8% (19/242) of enriched samples (Caprioli *et al*., [@ref14]). Bonardi *et al*. ([@ref7]) performed a later study, which showed a low portion of STEC O157-positive faecal samples in Italy. STEC O157 was isolated from the intestinal content of one (0.7%) of 150 tested pigs. Similarly, in a Dutch study, Heuvelink and colleagues ([@ref34]) isolated *E. coli* O157 strains from two rectal contents of 145 tested pigs (1.4%), but only one (0.7%) harboured the *stx2* gene. In addition, as part of the national Dutch monitoring programme in farms, 1,122 pooled faecal samples were collected from 229 finishing pig herds and 0.4% (1/229) were found to have *E. coli* O157 that was positive with the isolation methods (Schouten *et al*., [@ref63]). A lower prevalence of STEC O157:H7 was reported from pigs slaughtered at five Swedish facilities: STEC O157:H7 was isolated from two of 2,446 individual faecal samples, indicating a prevalence of 0.08% (Eriksson *et al*., [@ref14]). Beutin *et al*. ([@ref3]) analysed 120 swine faecal specimens collected in Germany and STEC was isolated from nine pigs (7.5%), but none of the isolates belonged to the O157 serogroup.

In the United States, STEC detection in the swine population has also been reported (Tseng *et al*., [@ref69]). A study was published in 2003, in which colon samples were obtained from pigs at slaughter. Six (1.97%) of the 305 colon samples gave isolates positive for *rfb*~O157~ and *fliC*~H7~ genes of the O157:H7 serotype, as well as for *stx* genes (Feder *et al*., [@ref25]). Interestingly, no STEC O157:H7 strain was isolated in the National Animal Health Monitoring System's Swine 2000 study. In this study, out of a total of 687 swine faecal samples tested for the presence of *stx1* and *stx2* using PCR assays, 484 (70%) of the samples were positive for one or both genes and at least one STEC isolate was recovered from the 196 faecal samples (196/687, 28.5%). It is noteworthy that about 80% of STEC isolates harboured *stx~2e~* and no strain of serogroup O157 was found (Fratamico *et al*., [@ref28]; Tseng *et al*., [@ref69]). A higher isolation rate was obtained in a longitudinal study, in which the STEC faecal shedding from the beginning to the end of the finishing period in 150 pigs was analysed. A total of 1,200 faecal samples were collected (eight collections for each pig) and STEC isolates were recovered in the last sample from 65.3% (98/150) of the pigs. Most of the STEC strains (97.9%) carried the *stx~2e~* gene and *E. coli* O157:H7 was not isolated (Tseng *et al*., [@ref70]). Also, in another study conducted in Chile, a high STEC prevalence was estimated. STEC strains were identified by DNA hybridisation in 68.3% (82/120) of the faecal samples of 120 healthy pigs (Borie *et al*., [@ref9]). Otherwise, other South American studies reported lower values of STEC prevalence. In Brazil, one study estimated a prevalence of 1.35% (1/74), assessed by isolation of one *stx2-*positive strain from 74 swine intestinal samples (Martins *et al*., [@ref5]). A later study, also performed in Brazil, used PCR to detect *stx2* or *stx2* and *eae* genes in 40 of 226 faecal samples, but no STEC isolate was obtained (Borges *et al*., [@ref8]).

The presence of STEC in swine populations was also documented in Asia (Tseng *et al*., [@ref69]). A Japanese national surveillance report stated that STEC isolates were recovered from 32 (14%) of 179 faecal samples. Among the isolates, *stx~2e~* were dominant and serotypes frequently implicated in human diseases or *eae*-positive stains were not observed (Kijima-Tanaka *et al*., [@ref45]; Tseng *et al*., [@ref69]). Out of 1003 samples (326 faecal specimens and 677 intestinal contents) analysed in a study conducted in China, 255 (25.4%) were *stx*-positive using PCR. A total of 93 STEC isolates were obtained from 62 samples, giving a culture positive rate of 6.2% (62/1003), and all of isolates harboured the *stx~2e~* subtype (Meng *et al*., [@ref51]). The prevalence of STEC was also investigated in 720 faecal samples randomly collected from a commercial breeding farm in China during a one-year surveillance period. Eight strains (1.1%) of sorbitol-negative STEC O157 and 33 strains (4.6%) of STEC non-O157 were isolated (Yan *et al*., [@ref29]). In a study performed in Hong Kong, *stx*-positive strains were isolated from 5.1% of 487 swine faecal samples, but only 2.1% (10/487) were confirmed as Shiga-toxin producing using the Vero-cell assay. The O157:H7 serotype was not isolated and the predominant genotype was *stx~2e~*-positive, *eaeA*-negative and *hlyA*-negative (Leung *et al*., [@ref11]). STEC strains were also isolated from pigs in India. A total of 782 rectal swabs were collected from clinically healthy and diarrhoeic piglets. STEC strains were detected in 113 (14.4%) samples: STEC O157 was isolated from four piglets (0.5%) and non-O157 STEC was isolated from 109 (13.9%) animals (Rajkhowa and Sarma, [@ref57]).

Pigs as potential reservoirs for STEC have also been reported in Africa. In a South Africa study, three STEC strains (1.1%) were isolated from 263 swine faecal samples. All of the strains harboured *stx~2e~* subtype (Mohlatlole *et al*., [@ref52]). Another study investigated the presence of seven potentially pathogenic STEC serogroups (O157, O26, O91, O103, O11, O128 and O145) in the faeces of 409 pigs in Ibadan, Nigeria. STEC strains were found in 23 faecal samples (5.7%): 20 isolates (4.9%) belonged to O157 serogroup, one (0.3%) to O26 serogroup, and two (0.5%) to O111 (Ojo *et al*., [@ref54]).

These studies show that the incidence of STEC in swine populations varied in multiple regions of the world. The observed differences could be due to variances in husbandry practices and prevailing climatic conditions of the geographical area being studied (Rajkhowa and Sarma, [@ref57]). The variation in methods used for the detection and isolation of STEC may be a factor contributing to differences among prevalence measurements (Fratamico *et al*., [@ref28]).

Similarly, several studies conducted in European countries reported wide-ranging estimates of STEC prevalence from swine carcasses and pork products. In Belgium, five pig carcasses (12.8%) from 132 examined were *stx*-positive in PCR (Bottledoorn *et al*., [@ref10]). A study conducted in Italy showed that, of the 150 carcasses examined by using immunomagnetic separation (IMS) techniques, only one (0.7%) was contaminated by STEC O157 (Bonardi *et al*., [@ref7]). In France, the swine carcass STEC contamination rate, detected using molecular methods, varied from 12% to 50% (Bouvet *et al*., [@ref11], [@ref12]). The highest prevalence was reported in 150 pig carcasses. For each carcass, eight sites were sampled using destructive methods. A total of 1200 specimens were analysed with PCR and a high percentage (50%, 75/150) of *stx*-positive samples was found (Bouvet *et al*., [@ref11]). A later study analysed the effects of slaughter processes on pig carcass STEC contamination. In this study, 182 carcasses were sampled at different steps of the slaughter process. The contamination rates were 46% (83/182) after bleeding, 16% (29/182) after dressing and 15% (28/182) after chilling using PCR analysis. Moreover, environmental samples were collected in different sites of the slaughterhouses at different times during the workday. Global carcass contamination decreased with the slaughter process, whereas environmental contamination increased. These results show that regular cleaning-disinfecting during the slaughter process could avoid, or at least decrease, the risk of STEC cross-contamination of carcasses (Bouvet *et al*., [@ref13]). Another French study evaluated the effects of the cutting process on pork meat STEC contamination. In total, 525 pig carcass samples were collected, as well as 525 untrimmed cut samples and 550 rindlessboneless cuts. Contamination rates were 12% (61/525), 19% (99/525) and 5% (28/559) respectively, showing a significant increase of STEC contamination, in particular, during the primary cutting process. Among the pork samples tested, none gave a positive result with PCR for *E. coli* O157:H7 (Bouvet *et al*., [@ref12]). Some other European studies reported STEC presence in pork products. An Italian study analysed 126 fresh pork sausages for the presence of STEC using PCR and isolation methods. Out of 126 samples screened using PCR, 20 (15.9%) were positive for *stx* genes. In particular, 50% of the *stx*-positive pork specimens (10/20) were contaminated with O157:H7 *E. coli*, giving positive results for the *rfbE*~O157:H7~ gene. Moreover, 24 *stx-*positive strains were isolated from 13 *stx*-positive samples (10.3%, 13/126) and 15 were shown to have the O157 serotype (Villani *et al*., [@ref71]). Another Italian study, conducted by Bardasi *et al*., ([@ref1]) reported data from a two-year STEC monitoring plan carried out in the Emilia Romagna Region. A total of 689 meat samples from different species were collected and analysed according to ISO/TS 13136, including 213 pork samples. STEC virulence genes were detected in 41 out of 213 (19%) fresh sausages from pork meat and one STEC strain of *E. coli* O103 *eae* and *stx1*-positive was isolated (Bardasi *et al*., [@ref1]). In UK, testing of pork sausages by DNA hybridisation showed the presence of STEC in 46 (25%) of 184 samples (Smith *et al*., [@ref64]). In Austria, from 120 pork meat samples, two (1.7%) Shiga toxin-producing *E. coli* strains were isolated (Mayrhofer *et al*., [@ref50]).

A wide range of values has also been reported from pork products and carcass samples collected in many countries. In the USA, STEC detection by DNA hybridisation in pork meat was reported in 18% (9/51) of 51 samples collected from Seattle area grocery stores (Samadpour *et al*., [@ref60]). More recently, a study was published in which 231 ground pork samples were collected in the Washington D.C. area. Among the 231 samples, 31 (13.4%) were positive for the *stx* gene using PCR screening. Positive specimens were further analysed using colony hybridisation, and STEC was isolated from 13 (5.2%) of the pork samples. All of the STEC isolates were negative for O157 serogroups (Ju *et al*., [@ref40]). In Canada, Read *et al*. ([@ref59]) examined the prevalence of STEC in 235 ground pork samples. Based on the neutralisation of cytotoxic activity in the Vero-cell assay, the prevalence of STEC was 10.6% (25/235). Isolations of STEC were obtained from nine (3.8%) of the pork samples. Positive results were obtained for 51 (4.8%) of 1067 carcasses tested using PCR for *stx* genes (bohaychuk *et al.*, [@ref5]) Borges *et al*. ([@ref8]) examined the presence of STEC in 215 swine carcasses using PCR and isolation techniques in Brazil. Shiga-toxin encoding genes were detected in 12 samples (5.6%), and the prevalence of STEC isolates was 0.4% (1/215). The STEC isolate identified in this study was positive for *stx~2e~* and did not belong to the O157:H7 serotype. In Asia, Leung *et al*. ([@ref47]) tested 487 pig carcass samples collected in an abattoir in Hong Kong. Strains positive for *stx*, using PCR, were obtained from 2.3% of samples and they were also tested with a Vero-cell cytotoxicity assay. Shiga toxin-producing *E. coli* was isolated from only one pig carcass. In an African study, the presence of seven potentially pathogenic STEC serogroups (O157, O26, O91, O103, O11, O128 and O145) was investigated in 200 pork samples collected in Nigeria. STEC strains were found in eight samples (4%), with six isolates belonging to the O157 serogroup (3%, 6/200) (Ojo *et al*., [@ref54]).

Although human disease associated with swine STEC is uncommon, outbreaks and cases of illness due to different STEC serotypes have occurred worldwide (Fratamico *et al*., [@ref28]). Pork products have only been reported as a vehicle involved in outbreaks of STEC O157 infections in a few instances. In Ontario, Canada, an outbreak of *Escherichia coli* O157:H7 occurred in 1998. Genoa salami, made with pork and beef, was identified as the most probable source of the outbreak (Williams *et al*., [@ref74]). Similarly, in 1999, an outbreak of STEC O157:H7 infections was identified in British Columbia. The case-control study found that the infection was significantly associated with salami consumption. This product was obtained from raw pork, but also from raw beef (MacDonald *et al*., [@ref48]). Pork was also implicated in a STEC O157:H7 outbreak in Ontario in 2011. Pork from a pig roast was identified as the most probable source of the STEC infection (Troz-Williams *et al*., [@ref68]). In Italy in 2004, a family outbreak of STEC O157 infection was reported, associated with the consumption of dry-fermented salami made with pork meat only and produced in a local plant. *E. coli* O157 non-motile strains were isolated from the patients that were hospitalised with bloody diarrhoea carried *stx1*, *stx2* and *eae* genes (Conedera *et al*., [@ref16]). In Australia, a locally produced dry fermented sausage, made with a mixture of raw pork, beef and lamb, was identified as the source of an outbreak of HUS in 1995. STEC isolates belonged to the serotype O111:H- and harboured *stx1* and *stx2* genes (Paton *et al*., [@ref56]). Although there are few reports of STEC outbreaks implicating pork as the likely source of infection, the results of these investigations emphasise the importance of considering other meat products besides beef as potential vehicle of STEC transmission (Troz-Williams *et al*., [@ref68]; Tseng *et al*., [@ref69]).

Differences between human and swine Shiga toxin-producing Escherichia coli strains {#sec1-3}
==================================================================================

Although pigs are a potential reservoir for STEC strains, different genetic profiles are described in STEC of swine origin and human origin (Sonntag *et al*., [@ref66]). Typical swinepathogenic *E. coli* strains include oedema disease and post-weaning diarrhoea-causing *E. coli*, which generally express haemolysin (encoded by *hly* gene), F18 fimbrial adhesin (encoded by *fedA* gene), adhesin involved in diffuse adherence (AIDA), F4 fimbriae (K88) and Shiga-like toxin 2e. Porcine pathogenic *E. coli* strains usually belong to a limited number of serogroups (O8, O108, O138, O139, O141, O147 and O149), which differ from those commonly associated with *stx~2e~*-positive human isolates (Sonntag *et al*., [@ref66]; Schierack *et al*., [@ref62]). Interestingly, *stx~2e~*-producing STEC belonging to serogroup O101, reported in human cases, has been isolated from slaughtered pigs, suggesting that pigs could be the natural reservoir of O101 strains (Caprioli *et al*., [@ref15]).

In contrast to Stx1 and Stx2, which are encoded in the genome of temperate bacteriophages, the *stx~2e~* gene in STEC associated with oedema disease has been reported to be located in the chromosome, because no Stx-converting phages could be isolated from such strains (Muniesa *et al*., [@ref53]). Stx~2e~-producing strains are also isolated from food, the environment and, albeit rarely, from humans. A lambdoid phage, called P27, carrying an *stx~2e~* gene, was isolated from a human STEC strain, but inducible *stx-*carrying phages were not found in other types of stx~2e~-producing strains from different origins (Muniesa *et al*., [@ref53]; Beutin *et al*., [@ref4]). Nevertheless, only in a few cases have *stx~2e~*-positive strains been detected from humans, accounting for only 0.9 to 1.7% of human STEC isolates (Sonntag *et al*., [@ref66]; Beutin *et al*., [@ref4]). Stx~2e~-producing STEC has especially been found in patients showing mild diarrhoea or in asymptomatic carriers. However, severe clinical symptoms, such as HUS, are described (Thomas *et al*., [@ref67]; Fasel *et al*., [@ref24]). In these human cases, no particular source of infection has been identified (Tseng *et al*., [@ref69]).

Additionally, stx~2e~ differs from other Shigatoxins by having particular receptor specificity. The B-subunits of Shiga-like toxins generally recognise cell surface glycolipid globotriaosylceramide (Gb3), and to a lesser extent, globotetraosyceramide (Gb4) as receptors (Karve and Weiss [@ref43]). In the pathogenesis of pig oedema disease, stx~2e~ enters the bloodstream and binds prevailingly to the receptor Gb4, which is located on the epithelial and endothelial cells. The toxin-induced blood vessel damage causes oedema, ataxia and death in swine (Tseng *et al*., [@ref69]). The finding that high-stx~2e~-producing strains are isolated from humans with no or only mild enteric symptoms suggests a lack of Gb4 and Gb3 receptors in human enterocytes (Beutin *et al*., [@ref4]).

Moreover, Sonntag *et al*. ([@ref66]) found that all of the 13 *stx~2e~*-containing strains isolated from 11,056 human stools adhered to human intestinal epithelial cell lines T84 and HCT-8, but not to pig intestinal epithelial cell line IPEC-J2. In contrast, most of the *stx~2e~*- harbouring *E. coli* isolated from piglets with oedema disease and post-weaning diarrhoea completely lysed human intestinal epithelial cells and adhered to IPEC-J2 cells. In the analysis of genetic profiles, stx~2e~-producing strains isolated from humans lack swine virulence factors, such as AIDA and F18 adhesins, and do not belong to serogroups O138, O139 and O141. These data indicate that stx~2e~-producing STEC strains show host-specific patterns of interaction with intestinal epithelial cells and specific virulence factors, which allow them to adapt to the hosts and cause various forms of disease.

Molecular and microbiological methods for Shiga toxin-producing *Escherichia coli* detection in the swine production chain {#sec1-4}
==========================================================================================================================

The STEC pathogroup comprises over 400 serotypes that differ greatly in both their pathogenic profile and their phenotypic characteristics. This diversity is reflected in the application of a wide range of detection methods in scientific studies, monitoring programmes, official food controls and human analysis laboratories (Holland *et al*., [@ref35]; Farrokh *et al*., [@ref23]). ISO 16654:2001 describes a microbiological method for the detection of *Escherichia coli* O157 in food and animal feeding stuffs, based on IMS (ISO, [@ref38]). In 2012, ISO approved a real-time PCR-based method (ISO/TS 13136:2012) for the detection of STEC and the determination of O157, O111, O26, O103 and O145 serogroups in food, animal feed and environmental samples in the areas of food production and primary production. The ISO 13136 method is comprised of these sequential steps: microbial enrichment, nucleic acid extraction, real-time PCR for the detection of virulence genes (*stx1*, *stx2* and eventually *eae*), detection of top-five serogroup-associated genes in *stx* and *eae*-positive samples, STEC isolation and molecular confirmation of isolates (ISO, [@ref39]).

An enrichment step is used with the aim of resuscitating stressed target cells, increasing the target cell number, and diluting the effects of matrix inhibitors and background flora on the assay (Wang *et al*., [@ref73]). Rantsiou *et al*. ([@ref58]) compared quantitative PCR (qPCR) protocols applied directly to food samples (including fresh and dry-fermented pork meat) and after a non-selective enrichment (37°C for 24h in Brain Heart Infusion broth); the number of *stx*-positive samples did not vary significantly between the two sampling points. Application of qPCR without enrichment allowed for a shortened analysis time and the quantification of real STEC contamination levels in food specimens. Nevertheless, the signal obtained in the direct qPCR could be originated from DNA of dead bacterial cells. After an enrichment step, the signal is necessarily associated with multiplying populations. Moreover, for STEC contamination levels below the qPCR assay detection limit, an enrichment step was deemed necessary (Rantsiou *et al*., [@ref58]).

In ISO 13136, the enrichment medium is chosen as a function of the sample types. In particular, modified tryptone-soy broth supplemented with novobiocin (m-TSB+N) is replaced by buffered peptone water (BPW) to analyse samples that are assumed to contain stressed target bacterial cells and low levels of contaminating microflora (such as frozen products). The addition of novobiocin is controversial and several authors have investigated it (ISO, [@ref39]). Although novobiocin is commonly added to m-TSB at concentrations of 20 mg/L to enrich STEC O157, as specified in ISO 16654, this antibiotic can inhibit the growth of some non-O157 STEC strains, and therefore ISO 13136 specified a lower concentration (16 mg/L), as indicated by Vimont *et al*. ([@ref72]). The authors analysed a minimum inhibitory concentration (MIC) of 74 *E. coli* O157:H7 and 55 non-O157:H7 STEC strains to novobiocin. The MIC values varied from 32 to \>64 mg/L for the 74 *E. coli* O157:H7 strains, and from 16 to \>64 mg/L for the 55 non-O157:H7 STEC strains, showing that the addition of novobiocin into enrichment broths can slow or inhibit the growth of some STEC strains. Kanki *et al*. ([@ref41]) noted that non-novobiocincontaining m-TSB enrichment medium exhibited superior ability to facilitate the detection of low numbers of non-O157 STEC cells in pure culture and food samples.

For the molecular analysis of STEC virulence genes in accordance with ISO 13136 norm, the nucleic acid extraction technique depends on the requirements of the adopted detection system (ISO, [@ref39]). The ideal DNA extraction protocol would provide the highest yield of DNA with minimal coextraction of potential inhibitors, coupled with a simple and rapid procedure (Holland *et al*., [@ref35]). Although DNA-based methods, such as PCR, are highly specific, reproducible, sensitive and characterised by high discriminatory power, they are strongly limited by the presence of inhibitors in the different samples. In particular, PCR inhibitors, such as polysaccharides and humic acids, are abundant in several types of food. The DNA extraction procedure, based on the use of silica-column systems, demonstrated high efficiency in DNA-binding and removing inhibitors with complex and processed food matrices (Di Pinto *et al*., [@ref17]). DNA extraction from faeces is challenging due to the presence of Taq polymerase inhibitors, which include heme, bilirubin, bile salts and complex carbohydrates and the nonuniformity of samples in terms of physical matter, target organisms and background flora. False-negative PCR results may be due to inhibitors, or to the presence of a small number of target organisms in the volume of faeces sampled or to the decreased stability of cells with storage (Holland *et al*., [@ref35]). Although direct extracts of faeces can be used as a template for PCR, sensitivity has often been suboptimal because of the presence of Taq polymerase inhibitors. For this reason, Paton *et al*. strongly recommended that faecal specimens be first cultured in a suitable enrichment medium (Paton and Paton, [@ref55]). Commercial kits that involve spin columns have been considered as suitable methods for the DNA extraction of STEC from human stool samples, as well as from animal faecal specimens (Holland *et al*., [@ref35]; Gioffré *et al*., [@ref31]).

Molecular methods based on the recognition of virulence genes and serogroups are increasingly used to characterise and delineate STEC from other forms of *E. coli* (Franz *et al*., [@ref27]). Since the early 1990s, numerous PCR assays have been developed to detect *stx1* and *stx2*. Although most PCR assays were fast and sensitive, performances varied when evaluated independently. With the advent of real-time PCR technology in the 2000s, great improvements were made in the speed and sensitivity of STEC detection. In addition, many PCR assays were developed for the detection of other virulence factors and STEC serogroups (Wang *et al*., [@ref73]). Besides the possible presence of assay inhibitors in the sample matrix, another caveat associated with PCR-based screening is the inability to differentiate dead from viable cells. The inclusion of internal amplification controls and the addition of viability dyes, such as propidium monoazide, have been developed to address those concerns. Moreover, the detection of virulence genes is not a guarantee of phenotypic gene expression and, in the case of multiple STEC strains contaminating a single sample, further confirmation is needed to determine whether the gene profiles detected belong to a single strain or to multiple different strains. The isolation of the strains is necessary to confirm that the positive PCR signals are generated from genes present in the same live STEC cell (Wang *et al*., [@ref73]).

Several studies have revealed the difficulty of obtaining STEC isolates from *stx*-positive enrichment cultures (Grant *et al*., [@ref32]). Although differential media have been developed to facilitate the isolation of *E. coli* O157:H7, these media are not generally effective for many STEC strains because of multiple reaction colours, due to sorbitol fermentation and β-D-glucuronidase activity. Also, several selective agar media, such as those containing novobiocin and tellurite, are enabled to support the growth of a significant portion of non-O157:H7 strains (Gill *et al*., [@ref30]). Failure to isolate STEC from *stx*-positive samples may also be due to the loss of Stx prophages during subculturing, the presence of other bacteria-carrying *stx*, the presence of *stx*-carrying phages, bacterial cells in a viable but non-culturable (VBNC) state, high levels of background microflora, or low levels of target bacteria in the sample (Ju *et al*., [@ref40]; Farrokh *et al*., [@ref23]; Meng *et al*., [@ref51]). ISO 13136 indicates that a serogroup-specific enrichment may be used to facilitate the isolation of STEC (ISO, [@ref39]). Commercial immunomagnetic separation assays are available for the selective concentration of the O157 serogroup and for a subset of few non-O157 serogroups most frequently involved in HUS outbreaks. The detection of this non-O157 STEC by IMS is subject to serogroup-specific variations in capture efficiency (Farrokh *et al*., [@ref23]). Colony-lift hybridisation procedures have also been applied in an effort to increase the isolation of non-O157 STEC strains when they are present at low levels relative to background microflora. The samples are plated out and hybridised onto membranes with *stx*-labelled probes to facilitate the isolation of non-O157 STEC (Wang *et al*., [@ref73]). However, many challenges related to non-O157 STEC detection still remain, since these are comprised of a heterogeneous group of pathogens with different phenotypic features (Smith *et al*., [@ref65]).

Currently, the rapidly evolving next generation of sequencing technologies are an emerging powerful tool that may potentially transform the methods used for identifying and characterising Shiga toxin-producing *E. coli* (Wang *et al*., [@ref73]). The continuing reduction in sequencing costs and the shortening of the *time-to-result* makes the whole genome sequencing an attractive strategy for improving different aspects of public health. This technology will increasingly influence diagnostics, risk management, epidemiology and research in the field of food safety (Franz *et al*., [@ref27]).

Discussion {#sec1-5}
==========

Although pigs are not generally considered relevant STEC reservoirs given the low known incidence of cases of severe human illness associated with STEC of swine origin, the role of swine in STEC epidemiology needs to be further investigated (Tseng *et al*., [@ref69]). The interaction of bacteriophages, the acquisition of pathogenicity islands, and horizontal gene transfer make the STEC genome highly flexible and dynamic (Franz *et al*., [@ref27]). Phagemediated transduction of virulence genes can generate highly virulent pathotypes (Imamovic *et al*., [@ref37]). Moreover, Stx phages are extremely persistent in the environment and pig wastewater shows higher densities of Stx phages than do cattle and poultry wastewater and urban sewage (Imamovic *et al*., [@ref37]). Because many of STEC virulence genes are located on mobile elements, the evolution of new STEC variants and the emergence of different sources of human infection cannot be neglected (Franz *et al*., [@ref27]). Recently, the European Shiga toxin-producing enteroaggregative *Escherichia coli* O104:H4 outbreak associated with fenugreek sprouts in 2011 provided a clear example of the importance of mobile elements in the acquisition of unusual virulence profiles and highlighted the pathogenic role of non-O157 STEC strains (Krüger and Lucchesi, [@ref46]). The emergence of non-O157 STEC serotypes has become a serious challenge for both the agri-food sector operators and public health authorities (Franz *et al*., [@ref27]). The severity of human illness and high mortality rate associated with STEC infection justify the growing attention of public health authorities to STEC and the inclusion of this group of bacteria as an important foodborne pathogen. However, the current monitoring activities performed as part of the Zoonoses Directive (2003/99/EC), although providing valuable data for individual Member States, lack harmonisation in places (EFSA, [@ref19]). The number of samples collected and types of food sampled varied among individual MS (EFSA and ECDC, [@ref20]). Application of monitoring programmes, good hygiene practices and efficient validated HACCP-procedures in the whole food production chain is an important instrument to control the public health risks associated with STEC infection (EFSA, [@ref19]). The prevention and control of foodborne diseases caused by STEC also require continuous improvement of analytical tools to understand the virulence, origins, and epidemiology of these bacteria, in order to devise strategies that lessen the risk of foodstuff contamination and eventually anticipate the emergence and the spreading of new forms of these pathogens (Franz *et al*., [@ref27]). Further investigations about the association between swine STEC and human illness can elucidate the epidemiology of STEC, particularly non-O157 serotypes (Tseng *et al*., [@ref69]).

Furthermore, the study of STEC mechanisms of action applied to animal models is a useful tool to understand the pathogenesis of human disease and develop new therapies. Because swine oedema disease shares many pathogenic similarities to HUS, including localised production of toxins in the gut, toxin translocation across intestinal epithelium and dissemination to target organs via the bloodstream, porcine models have been used in scientific studies for the development of novel post-exposure therapies for HUS in human beings, such as Stx receptor mimic probiotics, which should bind and neutralise Shiga-like toxins within the intestinal lumen (Hostetter *et al*., [@ref36]).

Conclusions {#sec1-6}
===========

Among the other practical implications related to the study of these bacteria, studies about the interactions between Shiga-like toxins and cell-surface-exposed glycosphingolipids suggest attractive perspectives in the field of oncology. Aberrant enhanced expressions of the Stx-receptor Gb3Cer/CD77 have been reported with various human solid tumours and have also been correlated with the development of metastasis in colon cancer. These data suggest the possible development, in the future, of targeted therapies based on Stx or Stx-derived constructs for patients with unresectable tumours or advanced cancer refractory to chemotherapy (Distler *et al*. [@ref18]).
